Patricia A Geoghegan (Patricia Geoghegan)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Biofilm Formation

Top Venues

Applied microbiology and biotechnology

Cellular and molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Leónidas Leiva, Adriana Cangelosi, Virginia Mariconda, Ana Celi, Patricia Joaquim, Patricia A Geoghegan, Mariano Fernández-Miyakawa, Pablo Chacana
Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom. Applied microbiology and biotechnology (2023)
Carlos Leónidas Leiva, Adriana Cangelosi, Virginia Mariconda, Ana Celi, Patricia Joaquim, Patricia A Geoghegan, Mariano Fernández-Miyakawa, Pablo Chacana
Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom. Applied microbiology and biotechnology 107 (5-6) (2023)
Carlos Leónidas Leiva, Adriana Cangelosi, Virginia Mariconda, Ana Celi, Patricia Joaquim, Patricia A Geoghegan, Mariano Fernández-Miyakawa, Pablo Chacana
Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom. Applied microbiology and biotechnology 107 (5-6) (2023)
Carlos Leónidas Leiva, Adriana Cangelosi, Virginia Mariconda, Ana Celi, Patricia Joaquim, Patricia A Geoghegan, Mariano Fernández-Miyakawa, Pablo Chacana
Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom. Applied microbiology and biotechnology 107 (5-6) (2023)
Clara Berdasco, Alipio Pinto, Mariano G Blake, Fernando Correa, Nadia A Longo Carbajosa, Ana B Celi, Patricia A Geoghegan, Adriana Cangelosi, Myriam Nuñez, Mariela M Gironacci, Jorge Goldstein
Cognitive Deficits Found in a Pro-inflammatory State are Independent of ERK1/2 Signaling in the Murine Brain Hippocampus Treated with Shiga Toxin 2 from Enterohemorrhagic Escherichia coli. Cellular and molecular neurobiology (2022)